DavidJGreenblattMD
Internal Medicine • Boston, MAAdult Clinical & Laboratory Immunology
Professor of Pharmacology and Experimental Therapeutics
Are you Dr. Greenblatt?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 60 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
Tufts Univ Sch Of Med
136 Harrison Avenue
Boston, MA 02111Phone+1 617-636-6997
Summary
- Dr. David Greenblatt, MD is an internist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts and Florida.
Education & Training
Massachusetts General HospitalResidency, Internal Medicine, 1973 - 1974
Boston University Medical CenterResidency, Internal Medicine, 1971 - 1972
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Internship, Internal Medicine, 1970 - 1971
Harvard Medical SchoolClass of 1970
Certifications & Licensure
MA State Medical License 1973 - 2025
FL State Medical License 2013 - 2017
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1983
Clinical Trials
- Effect of Ethanol and Genetic Polymorphisms on Bupropion Metabolism Start of enrollment: 2005 Dec 01
Publications & Presentations
PubMed
- 520 citationsEffect of Obesity on the Pharmacokinetics of Drugs in HumansMichael J. Hanley, Darrell R. Abernethy, David J. Greenblatt
Clinical Pharmacokinetics. 2010-01-01 - 34 citationsImipramine-cimetidine interaction: Impairment of clearance and enhanced absolute bioavailabilityDarrell R. Abernethy, David J. Greenblatt, Richard I. Shader
The Journal of Pharmacology and Experimental Therapeutics. 1984-06-01 - 8097 citationsA method for estimating the probability of adverse drug reactionsClaudio A. Naranjo, Usoa E. Busto, Edward M. Sellers, Paul Sandor, I Ruiz
Clinical Pharmacology and Therapeutics. 1981-08-01
Grant Support
- CYP3A Function In Aging AfricanamericansNational Institute On Aging2002–2006
- MDR1 And Related Proteins During HIV PI ExposureNational Institute Of Allergy And Infectious Diseases2005
- Collaboratory Extension To ChimeraNational Center For Research Resources2004–2005
- Chronic Benzodiazepines: Behavior And NeurochemistryNational Institute On Drug Abuse2001–2005
- CX516 (AMPALEX) In Healthy Elderly Males And FemalesNational Center For Research Resources2004
- Garlic Preparations And Antiretroviral DrugsNational Center For Complementary &Alternative Medicine2002–2004
- Haart Regimens In Substance AbusersNational Institute On Drug Abuse2001–2003
- Metabolic Consequences Of HAART: CYP3A And P-GPNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2003
- Antiretroviral Therapies And Substance AbuseNational Institute On Drug Abuse2000–2002
- Interaction Amitriptyline With Ketoconazole And QuinidineNational Center For Research Resources1997–2002
- Pharmacodynamic/Pharmacokinetics Study Of Zaleplon And ZolpidemNational Center For Research Resources1997–1999
- Chronic Benzodiazepines--Behavior And NeurochemistryNational Institute On Drug Abuse1994–1999
- Training In Geriatric PsychopharmacologyNational Institute Of Mental Health1994–1998
- Impairment Of Midazolam Metabolism By Coadministration Of KetoconazoleNational Center For Research Resources1997
- Pharmacokinetics/Dynamics Of Combined Ketoconazole/Triazolam/AlprazolamNational Center For Research Resources1996–1997
- Kinetic And Dynamic Study Of Adinazolam Desmethyladinazolam And AlprazolamNational Center For Research Resources1996
- Kinetic And Dynamic Study Of Adinazolam, Desmethyladinazolam And AlprazolamNational Center For Research Resources1995
- Chronic Benzodiazepines: Behavior And NeurochemistryNational Institute On Drug Abuse1991–1992
- Chronic Benzodiazepines;Behavioral &NeurochemistryNational Institute On Drug Abuse1987–1989
- Pharmacokinetics In The ElderlyNational Institute On Aging1985–1987
